MEI Pharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.07.24	MEI Pharma To Begin Evaluation Of Strategic Alternatives - Quick Facts (RTTNews)
13.06.23	MEI Pharma Hires Justin File As CFO To Succeed Brian Drazba (RTTNews)
02.06.23	MEI Pharma Promotes COO David Urso To Succeed Daniel Gold As President And CEO (RTTNews)
23.02.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNKB, PTRS, JNCE, MEIP (PR Newswire)
17.08.21	MEI Pharma and Kyowa Kirin Announce First Patient Dosed in the Phase 3 COASTAL Study Evaluating Zandelisib Plus Rituximab in Relapsed or Refractory Indolent Non Hodgkin's B-cell Lymphoma (PR Newswire)
05.08.21	MEI Pharma Announces Planned Chief Financial Officer Transition (PR Newswire)
02.08.21	MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
07.07.21	MEI Pharma Appoints Tina C. Beamon, J.D., as Chief Compliance Officer (PR Newswire)
01.07.21	MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
09.06.21	MEI Pharma and Kyowa Kirin to Present Clinical Data from Ongoing Studies Evaluating Zandelisib for Lymphoma at the 16th International Conference on Malignant Lymphoma Virtual Scientific Program (PR Newswire)
03.07.20	IMMU Continues Ascent, IDXG On Fire, REGN's Kevzara Disappoints In COVID-19 Trial, BLFS On Watch (RTTNews)
02.07.20	Helsinn, MEI Pharma Discontinue Phase 3 Study With Pracinostat - Quick Facts (RTTNews)
14.04.20	Stock Alert: MEI Pharma Shares Surge 77% In Pre-Market (RTTNews)
23.08.18	EXAS Soars On Pfizer Deal, MYND Delighted, ADMP Faces FDA In Sep. (RTTNews)
15.06.18	MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress (PR Newswire)
04.06.18	MEI Pharma Presents Phase 1b Clinical Data for ME-401 in Patients with Indolent B-Cell Malignancies at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
04.06.18	MEI Pharma Presents Clinical Data for ME-344 in HER2 Negative Breast Cancer Patients at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
03.06.18	An Ear To The Pharma: 9 Stocks To Watch (CTMX, ZEAL, MRSN...) (RTTNews)
31.05.18	MEI Pharma and Helsinn Group Announce Successful Interim Analysis of Pracinostat/Azacitidine Phase 2 Combination Study in Higher Risk Myelodysplastic Syndrome (MDS) Patients (PR Newswire)
16.05.18	MEI Pharma to Present Clinical Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
16.05.18	MEIP Gets Funded, PFNX Riding High, GNPX Turns Heads (RTTNews)
14.05.18	MEI Pharma Announces $75 Million Private Placement (PR Newswire)
09.05.18	MEI Pharma Reports Third Quarter Fiscal Year 2018 Results (PR Newswire)
30.04.18	Heska Names EVP, International Diagnostics, to Accelerate International Expansion (PR Newswire)
25.04.18	CJ CGV CEO Lays Out Cultureplex Concept As The Key To Growth Of Cinema Business (PR Newswire)
14.03.18	MEI Pharma To Present at Two Upcoming Investor Conferences (PR Newswire)
26.02.18	MEI Pharma Appoints Industry Veteran Frederick W. Driscoll to its Board of Directors (PR Newswire)
13.02.18	MEI Pharma Interim Data Review Supports Continuation of Clinical Study Evaluating ME-344 in Patients with Breast Cancer (PR Newswire)
08.02.18	MEI Pharma Reports Second Quarter Fiscal Year 2018 Results (PR Newswire)
06.02.18	Ball to Build Beverage Can Plant in Paraguay, Expand Capacity in Argentina (PR Newswire)
23.01.18	Water Pik, Inc. Teams With Tough Mudder to Introduce the First Ruff Mudder Dog Obstacle Course (PR Newswire)
11.01.18	Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of Acute Myeloid Leukemia (AML) (PR Newswire)
08.01.18	MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib (PR Newswire)
21.12.17	MEI Pharma Announces Study of Clinical Stage Oral CDK Inhibitor Voruciclib Published in Nature Scientific Reports (PR Newswire)
22.11.17	MEI Pharma to Host Annual Meeting of Stockholders (PR Newswire)
08.11.17	MEI Pharma Reports First Quarter Fiscal Year 2018 Results (PR Newswire)
07.11.17	MEI Pharma to Present at Stifel 2017 Healthcare Conference (PR Newswire)
19.09.17	MEI Pharma to Present at Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
06.09.17	MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet (RTTNews)
05.09.17	MEI Pharma Announces Exclusive License Agreement with Presage Biosciences for Voruciclib, An Oral, Selective CDK Inhibitor (PR Newswire)
31.08.17	MEI Pharma to Present at Two Upcoming Investor Conferences (PR Newswire)
29.08.17	MEI Pharma to Host Fiscal Year End Conference Call on September 5, 2017 (PR Newswire)
07.08.17	Drug Makers Stock Performance Review -- DURECT, Sucampo Pharma, Apricus Biosciences, and MEI Pharma (PR Newswire)
02.08.17	Helsinn Group and MEI Pharma Announce First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia (PR Newswire)
27.07.17	Lendio Surpasses $500 Million in Business Loans Originated Through Its Online Marketplace (PR Newswire)
14.06.17	Helsinn Group and MEI Pharma Announce First Patient Dosed in Phase 2 Dose-Optimization Study of Pracinostat and Azacitidine in Myelodysplastic Syndrome (PR Newswire)
05.06.17	Helsinn Group and MEI Pharma Report Correlation between Mutations in DNA Methylation Pathway and Clinical Response in Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia (PR Newswire)
31.05.17	MEI Pharma Announces Pre-Specified Response Rate Exceeded in Dose-Escalation Study of ME-401 in Chronic Lymphocytic Leukemia and Follicular Lymphoma (PR Newswire)
18.05.17	Helsinn Group and MEI Pharma Announce Upcoming Presentations of Gene Mutation and Clinical Response Data from Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia (PR Newswire)
04.05.17	MEI Pharma Reports Third Quarter Fiscal Year 2017 Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	597.60	2.68 %	K V
Novartis	96.09	0.53 %	K V
Nestle	77.86	0.49 %	K V
Roche Hldg G	285.70	-0.10 %	K V
Zurich Insur Gr	553.20	-0.11 %	K V
UBS Group	31.79	-1.70 %	K V
ABB	49.03	-1.84 %	K V
Kuehne+Nagel Int	203.20	-2.12 %	K V
Sika	227.60	-2.44 %	K V
Logitech Intl	88.62	-3.13 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu MEI Pharma

Aktien Top/Flop

Meistgelesene Nachrichten